The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds’ and investors’ portfolio positions as of June 30th, when the S&P 500 Index was trading around the 3100 level. Since the end of March, investors decided to bet on the economic recovery and a stock market rebound. S&P 500 Index returned more than 50% since its bottom. In this article you are going to find out whether hedge funds thought Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)¬†was a good investment heading into the third quarter and how the stock traded in comparison to the top hedge fund picks.

Is Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) an exceptional investment right now? Money managers were taking a bullish view. The number of long hedge fund positions improved by

Read More